Zelie Bailes
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Safety, Tolerability, and Pharmacokinetics of Oral Camlipixant: A Randomized First-In-Human Study Using Single and Multiple Ascending Doses.
Journal: Journal of clinical pharmacology
Published: March 06, 2026
Clinic vs Home Spirometry for Monitoring Lung Function in Patients With Asthma.
Journal: Chest
Published: February 17, 2023
Measuring respiratory symptoms in moderate/severe asthma: evaluation of a respiratory symptom tool, the E-RS®: COPD in asthma populations.
Journal: Journal of patient-reported outcomes
Published: November 09, 2020
Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial.
Journal: The Lancet. Respiratory medicine
Published: August 04, 2020
A phase IIb, randomised, parallel-group study: the efficacy, safety and tolerability of once-daily umeclidinium in patients with asthma receiving inhaled corticosteroids.
Journal: Respiratory research
Published: November 01, 2019
Oral glucose lowering with linagliptin and metformin compared with linagliptin alone as initial treatment in Asian patients with newly diagnosed type 2 diabetes and marked hyperglycemia: Subgroup analysis of a randomized clinical trial.
Journal: Journal of diabetes investigation
Published: April 03, 2017
Linagliptin plus metformin in patients with newly diagnosed type 2 diabetes and marked hyperglycemia.
Journal: Postgraduate medicine
Published: September 30, 2016
Subgroup analysis of Asian patients in the INPULSIS® trials of nintedanib in idiopathic pulmonary fibrosis.
Journal: Respirology (Carlton, Vic.)
Published: January 07, 2016
Efficacy and safety of linagliptin co-administered with low-dose metformin once daily versus high-dose metformin twice daily in treatment-naïve patients with type 2 diabetes: a double-blind randomized trial.
Journal: Advances in therapy
Published: November 26, 2014
Initial combination of linagliptin and metformin compared with linagliptin monotherapy in patients with newly diagnosed type 2 diabetes and marked hyperglycaemia: a randomized, double-blind, active-controlled, parallel group, multinational clinical trial.
Journal: Diabetes, obesity & metabolism
Published: July 22, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026